María del Val Bermejo Sanz-rekin lankidetzan egindako argitalpenak (28)

2018

  1. Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways and intestinal efflux transporter

    European Journal of Pharmaceutical Sciences, Vol. 117, pp. 193-203

  2. Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation

    European Journal of Pharmaceutical Sciences, Vol. 119, pp. 200-207

  3. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits

    European Journal of Pharmaceutical Sciences, Vol. 120, pp. 123-132

2017

  1. Enhancing Oral Absorption of β-Lapachone: Progress Till Date

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 42, Núm. 1

  2. IVIVC approach based on carbamazepine bioequivalence studies combination

    Pharmazie, Vol. 72, Núm. 8, pp. 449-455

2016

  1. Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution Profiles

    AAPS Journal, Vol. 18, Núm. 6, pp. 1550-1561

  2. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 41, Núm. 6, pp. 795-806

  3. Population pharmacokinetic model of lithium and drug compliance assessment

    European Neuropsychopharmacology, Vol. 26, Núm. 12, pp. 1868-1876

2015

  1. Blood-brain barrier and drug delivery

    Advances in Non-Invasive Drug Delivery to the Brain (Future Medicine Ltd.), pp. 6-20

  2. Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties

    Journal of Medicinal Chemistry, Vol. 58, Núm. 15, pp. 5825-5841

  3. Drug gastrointestinal absorption in rat: Strain and gender differences

    European Journal of Pharmaceutical Sciences, Vol. 78, pp. 198-203

  4. In vitro methods for assessing drug access to the brain

    Advances in Non-Invasive Drug Delivery to the Brain (Future Medicine Ltd.), pp. 44-61

  5. In vitro-in vivo correlations: General concepts, methodologies and regulatory applications

    Drug Development and Industrial Pharmacy, Vol. 41, Núm. 12, pp. 1935-1947

  6. Investigating the Discriminatory Power of BCS-Biowaiver in Vitro Methodology to Detect Bioavailability Differences between Immediate Release Products Containing a Class i Drug

    Molecular Pharmaceutics, Vol. 12, Núm. 9, pp. 3167-3174

  7. Semi-physiologic model validation and bioequivalence trials simulation to select the best analyte for acetylsalicylic acid

    European Journal of Pharmaceutical Sciences, Vol. 74, pp. 86-94

  8. Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors

    British Journal of Pharmacology, Vol. 172, Núm. 3, pp. 829-840

  9. Validation of a semi-physiological model for caffeine in healthy subjects and cirrhotic patients

    European Journal of Pharmaceutical Sciences, Vol. 73, pp. 57-63

  10. Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers

    Journal of Pharmacological and Toxicological Methods, Vol. 71, pp. 21-32

2014

  1. A promising camptothecin derivative: Semisynthesis, antitumor activity and intestinal permeability

    European Journal of Medicinal Chemistry, Vol. 83, pp. 366-373

  2. Modified nonsink equation for permeability estimation in cell monolayers: Comparison with standard methods

    Molecular Pharmaceutics, Vol. 11, Núm. 5, pp. 1403-1414